Literature DB >> 20382026

Where does amantadine bind to the influenza virus M2 proton channel?

Dima Kozakov1, Gwo-Yu Chuang, Dmitri Beglov, Sandor Vajda.   

Abstract

Structures of the influenza A virus M2 proton channel in the open conformation have been determined by X-ray crystallography, and in the closed conformation by NMR. Whereas the X-ray structure shows a single inhibitor molecule in the middle of the channel, four inhibitor molecules bind the channel's outer surface in the NMR structure. In both structures, the strongest hot spots (i.e., regions that contribute substantially to the free energy of binding any potential ligand) lie inside the pore, and other hot spots are found at exterior locations. By considering all available models, we propose the primary drug binding site is inside the pore, but that exterior binding occurs under appropriate conditions. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20382026      PMCID: PMC2919587          DOI: 10.1016/j.tibs.2010.03.006

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  45 in total

1.  Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites.

Authors:  Alasdair T R Laurie; Richard M Jackson
Journal:  Bioinformatics       Date:  2005-02-08       Impact factor: 6.937

2.  Druggability indices for protein targets derived from NMR-based screening data.

Authors:  Philip J Hajduk; Jeffrey R Huth; Stephen W Fesik
Journal:  J Med Chem       Date:  2005-04-07       Impact factor: 7.446

3.  Identification of hot spots within druggable binding regions by computational solvent mapping of proteins.

Authors:  Melissa R Landon; David R Lancia; Jessamin Yu; Spencer C Thiel; Sandor Vajda
Journal:  J Med Chem       Date:  2007-02-17       Impact factor: 7.446

4.  Antiviral resistance in influenza viruses--implications for management and pandemic response.

Authors:  Frederick G Hayden
Journal:  N Engl J Med       Date:  2006-02-23       Impact factor: 91.245

Review 5.  Locating and characterizing binding sites on proteins.

Authors:  C Mattos; D Ringe
Journal:  Nat Biotechnol       Date:  1996-05       Impact factor: 54.908

Review 6.  Controlling influenza virus replication by inhibiting its proton channel.

Authors:  Lawrence H Pinto; Robert A Lamb
Journal:  Mol Biosyst       Date:  2006-11-22

7.  Transmembrane four-helix bundle of influenza A M2 protein channel: structural implications from helix tilt and orientation.

Authors:  F A Kovacs; T A Cross
Journal:  Biophys J       Date:  1997-11       Impact factor: 4.033

8.  Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.

Authors:  Rick A Bright; David K Shay; Bo Shu; Nancy J Cox; Alexander I Klimov
Journal:  JAMA       Date:  2006-02-02       Impact factor: 56.272

9.  Backbone structure of the amantadine-blocked trans-membrane domain M2 proton channel from Influenza A virus.

Authors:  Jun Hu; Tom Asbury; Srisairam Achuthan; Conggang Li; Richard Bertram; Jack R Quine; Riqiang Fu; Timothy A Cross
Journal:  Biophys J       Date:  2007-03-23       Impact factor: 4.033

10.  The chemical and dynamical influence of the anti-viral drug amantadine on the M2 proton channel transmembrane domain.

Authors:  Jun Hu; Riqiang Fu; Timothy A Cross
Journal:  Biophys J       Date:  2007-04-13       Impact factor: 4.033

View more
  20 in total

1.  Coexistence of two adamantane binding sites in the influenza A M2 ion channel.

Authors:  Matthew R Rosenberg; Marco G Casarotto
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-19       Impact factor: 11.205

2.  Conjugation to polymeric chains of influenza drugs targeting M2 ion channels partially restores inhibition of drug-resistant mutants.

Authors:  Alyssa M Larson; Jianzhu Chen; Alexander M Klibanov
Journal:  J Pharm Sci       Date:  2013-07-06       Impact factor: 3.534

Review 3.  Structural basis for proton conduction and inhibition by the influenza M2 protein.

Authors:  Mei Hong; William F DeGrado
Journal:  Protein Sci       Date:  2012-10-09       Impact factor: 6.725

Review 4.  Obstructing toxin pathways by targeted pore blockage.

Authors:  Ekaterina M Nestorovich; Sergey M Bezrukov
Journal:  Chem Rev       Date:  2012-10-11       Impact factor: 60.622

5.  Exploring the structural origins of cryptic sites on proteins.

Authors:  Dmitri Beglov; David R Hall; Amanda E Wakefield; Lingqi Luo; Karen N Allen; Dima Kozakov; Adrian Whitty; Sandor Vajda
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-26       Impact factor: 11.205

6.  Benchmark Sets for Binding Hot Spot Identification in Fragment-Based Ligand Discovery.

Authors:  Amanda E Wakefield; Christine Yueh; Dmitri Beglov; Marcelo S Castilho; Dima Kozakov; György M Keserű; Adrian Whitty; Sandor Vajda
Journal:  J Chem Inf Model       Date:  2020-12-08       Impact factor: 4.956

7.  Structural basis for the function and inhibition of an influenza virus proton channel.

Authors:  Amanda L Stouffer; Rudresh Acharya; David Salom; Anna S Levine; Luigi Di Costanzo; Cinque S Soto; Valentina Tereshko; Vikas Nanda; Steven Stayrook; William F DeGrado
Journal:  Nature       Date:  2008-01-31       Impact factor: 49.962

8.  Comprehensive experimental and computational analysis of binding energy hot spots at the NF-κB essential modulator/IKKβ protein-protein interface.

Authors:  Mary S Golden; Shaun M Cote; Marianna Sayeg; Brandon S Zerbe; Elizabeth A Villar; Dmitri Beglov; Stephen L Sazinsky; Rosina M Georgiadis; Sandor Vajda; Dima Kozakov; Adrian Whitty
Journal:  J Am Chem Soc       Date:  2013-04-10       Impact factor: 15.419

9.  New Frontiers in Druggability.

Authors:  Dima Kozakov; David R Hall; Raeanne L Napoleon; Christine Yueh; Adrian Whitty; Sandor Vajda
Journal:  J Med Chem       Date:  2015-08-11       Impact factor: 7.446

10.  Focused grid-based resampling for protein docking and mapping.

Authors:  Artem B Mamonov; Mohammad Moghadasi; Hanieh Mirzaei; Shahrooz Zarbafian; Laurie E Grove; Tanggis Bohnuud; Pirooz Vakili; Ioannis Ch Paschalidis; Sandor Vajda; Dima Kozakov
Journal:  J Comput Chem       Date:  2016-02-02       Impact factor: 3.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.